A phase I study of sorafenib in combination with S-1 plus cisplatin in patients with advanced gastric cancer

Author： Yamada Yasuhide   Kiyota Naomi   Fuse Nozomu   Kato Ken   Minami Hironobu   Hashizume Kensei   Kuroki Yoshihiro   Ito Yuichiro   Ohtsu Atsushi  

Publisher： Springer Publishing Company

ISSN： 1436-3291

Source： Gastric Cancer, Vol.17, Iss.1, 2014-01, pp. : 161-172

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Phase I Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer

By Kimura Yutaka   Yano Hiroshi   Imamura Hiroshi   Fujitani Kazumasa   Imano Motohiro   Tokunaga Yukihiko   Matsuoka Masaki   Kurokawa Yukinori   Shimokawa Toshio   Takiuchi Hiroya   Tsujinaka Toshimasa   Furukawa Hiroshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 125-131

Oxford University Press

Access to resources Recommend Favorite

Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer

By Ueda Yuji   Yamagishi Hisakazu   Ichikawa Daisuke   Okamoto Kazuma   Otsuji Eigo   Morii Jun   Koizumi Kinya   Kakihara Naoki   Shimotsuma Masataka   Yamashita Tetsuro   Taniguchi Fumihiro   Aragane Hideki   Nishi Hiroshi   Itokawa Yoshiki   Morita Satoshi   Sakamoto Junichi  

Gastric Cancer, Vol. 13, Iss. 3, 2010-08 ,pp. : 149-154

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

By Kim Jong   Sohn Sang   Song Hong   Kwon Ki-Young   Do Young   Lee Kyung   Hyun Myung   Ryoo Hun   Bae Sung   Park Keon   Baek Jin   Lee Won   Chung Joo   Cho Goon   Sohn Chang-Hak   Jang Jung   Chung Ho   Yu Wansik  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer

By                                

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1297-1304

Spandidos Publications

Access to resources Recommend Favorite

A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer

By                                  

Oncology Letters, Vol. 2, Iss. 3, 2011-01 ,pp. : 465-470

Spandidos Publications

Access to resources Recommend Favorite